                         SEQUENCE LISTING

<110>  Avamab Pharma Inc.
 
<120>  METHODS FOR REGULATING ENDOGENOUS PRODUCTION OF ANTIBODIES 
       AGAINST INFECTIOUS DISEASES

<130>  A8141932WO

<140>  NOT YET AVAILABLE
<141>  2018-11-09

<150>  16/185,598
<151>  2018-11-09

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  1
caggtgcaac tcgtcgaaag cggcggaggc gtcgtccagc caggaagatc attgaggctt       60

tcttgcgcag cttcaggctt ctccttcagt aactatggta tgcactgggt ccggcaggcc      120

cctgggaaag ggctggaatg ggttgccctt atttggtacg acggtagcaa cgaggattac      180

acagattcag ttaagggacg gtttactatt tctagggaca acagtaaaaa caccctctat      240

cttcagatga acagccttcg cgctgaagac acagccgtat attattgcgc tagatggggg      300

atggtgcgag gtgtcatcga tgtgtttgac atttggggcc aaggaactgt tgttacagtg      360

agtagcgcc                                                              369


<210>  2
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  2
gacattcaaa tgactcaatc tccttcctcc gtctccgcat ccgtaggaga ccgggtgact       60

atcacttgtc gcgccagtca gggcatatcc agttggctgg catggtacca gcataagcca      120

ggaaaagccc caaaattgct gatatatgca gcatcaagtt tgcaatccgg ggtgccctcc      180

aggttctctg gtagtggaag cggtacagat ttcacactga caatcagcag tcttcaaccc      240

gaggacttcg ccacatatta ctgccagcag gctaacagct tcccctggac attcggccag      300

gggaccaagg tggaaattaa aaggacagtt gctgca                                336


<210>  3
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  3
gaagttcagt tggttcaatc aggcgctgag gttaagaaat ccggggagtc tttgaaaatc       60

agttgtaagg ggagcggata cagctttacc tcctattgga taggctgggt taggcaaatg      120

ccagggaagg gcctggaatg gatgggaata ttctaccctg gggattcatc cacacggtac      180

agtccatcct tccagggtca agttaccatt tctgctgata agagcgtgaa taccgcttac      240

ttgcaatgga gcagtctcaa agcaagcgac accgccatgt actattgcgc tcgcagaagg      300

aattggggca atgctttcga catatggggg cagggcacta tggttactgt gtccagtgca      360


<210>  4
<211>  339
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  4
gaaatagtgt tgactcaatc acctggaaca ctgtcattgt cacccggcga aagggccaca       60

ctgtcttgta gggccagtca gagtgtctct tcctcttacc tcgcttggta tcagcagaaa      120

cccggccagg ctccccggct gcttatatat ggagctagtt cccgcgctac aggtattcct      180

gatagattta gtggaagtgg tagcggaaca gactttacct tgactatctc acgacttgaa      240

cccgaggatt tcgccgtata ttattgtcaa caatacgggt caagtacatg gactttcggt      300

caaggtacaa aagttgaaat caaacggaca gttgctgcc                             339


